News
Novo Nordisk has launched Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce ...
Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...
10m
The Independent on MSNMounjaro is available on the NHS. Here’s what to do if you’re not eligibleMounjaro is available on the NHS. Here’s what to do if you’re not eligible - Mounjaro has been approved for both type 2 ...
Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks.
Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...
Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results